DNMT1 and Hearing impairment: Furthermore, reducing DNMT activity by injecting siDNMT1 prior to noise exposure mimicked RG108 administration, attenuating noise-associated OHC loss and the resulting hearing impairment, which indicates that alleviation of noise-related OHC loss and NIHL by RG108 treatment indeed relies on DNMT1 suppression.